These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1840228)
41. The effects of serotonin3 receptor blockade on the psychobiological response to intravenous clomipramine in healthy human subjects. Leatherman ME; Bebchuk JM; Ekstrom RD; Heine AD; Carson SW; Golden RN Biol Psychiatry; 1999 Jan; 45(2):238-40. PubMed ID: 9951573 [TBL] [Abstract][Full Text] [Related]
42. Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential. Greenshaw AJ Trends Pharmacol Sci; 1993 Jul; 14(7):265-70. PubMed ID: 8105596 [TBL] [Abstract][Full Text] [Related]
43. Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse. Costall B; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB Br J Pharmacol; 1989 Feb; 96(2):325-32. PubMed ID: 2522335 [TBL] [Abstract][Full Text] [Related]
44. Neuroanatomical structures involved in the action of the 5-HT3 antagonist ondansetron: a 2-deoxyglucose autoradiographic study in the rat. Mitchell EA; Pratt JA Brain Res; 1991 Jan; 538(2):289-94. PubMed ID: 1826459 [TBL] [Abstract][Full Text] [Related]
45. 5-HT3 receptor blockers. Smith RA Surgery; 1991 Sep; 110(3):575. PubMed ID: 1653465 [No Abstract] [Full Text] [Related]
46. The relevance of pharmacological studies to sleep research in psychiatry. Janssen PA Pharmacopsychiatry; 1988 Jan; 21(1):33-7. PubMed ID: 3129746 [TBL] [Abstract][Full Text] [Related]
47. 5-HT3 receptors: pharmacologic and therapeutic aspects. Gyermek L J Clin Pharmacol; 1995 Sep; 35(9):845-55. PubMed ID: 8786244 [TBL] [Abstract][Full Text] [Related]
51. Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine: a pilot study in healthy volunteers. Silverstone PH; Oldman D; Johnson B; Cowen PJ Int Clin Psychopharmacol; 1992; 7(1):37-43. PubMed ID: 1385603 [TBL] [Abstract][Full Text] [Related]
52. The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates. Barnes JM; Costall B; Coughlan J; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ; Onaivi ES; Tomkins DM; Tyers MB Pharmacol Biochem Behav; 1990 Apr; 35(4):955-62. PubMed ID: 2140610 [TBL] [Abstract][Full Text] [Related]
53. 5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system. Kilpatrick GJ; Hagan RM; Gale JD Behav Brain Res; 1996; 73(1-2):11-3. PubMed ID: 8788470 [TBL] [Abstract][Full Text] [Related]
54. The role of 5-HT3 receptors in drug dependence. Grant KA Drug Alcohol Depend; 1995 May; 38(2):155-71. PubMed ID: 7671767 [TBL] [Abstract][Full Text] [Related]
55. The central 5-HT3 receptor in CNS disorders. Bloom FE; Morales M Neurochem Res; 1998 May; 23(5):653-9. PubMed ID: 9566603 [TBL] [Abstract][Full Text] [Related]
56. Dopaminergic excitation in goat carotid body may be mediated by serotonin receptors. O'Halloran KD; Herman JK; Janssen PL; Bisgard GE Adv Exp Med Biol; 2000; 475():581-8. PubMed ID: 10849698 [No Abstract] [Full Text] [Related]
57. The effect of ondansetron on cognitive performance in the marmoset. Domeney AM; Costall B; Gerrard PA; Jones DN; Naylor RJ; Tyers MB Pharmacol Biochem Behav; 1991 Jan; 38(1):169-75. PubMed ID: 1826787 [TBL] [Abstract][Full Text] [Related]
58. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist. Jones BJ; Costall B; Domeney AM; Kelly ME; Naylor RJ; Oakley NR; Tyers MB Br J Pharmacol; 1988 Apr; 93(4):985-93. PubMed ID: 2898961 [TBL] [Abstract][Full Text] [Related]
59. Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice. Rodgers RJ; Shepherd JK; Randall JI Neuropharmacology; 1990 Jan; 29(1):17-23. PubMed ID: 2137563 [TBL] [Abstract][Full Text] [Related]
60. 5-HT3 receptors. Tyers MB Ann N Y Acad Sci; 1990; 600():194-202; discussion 202-5. PubMed ID: 2252310 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]